FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 94 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $109,000 | +78.7% | 23,764 | +50.2% | 0.00% | 0.0% |
Q3 2019 | $61,000 | -80.6% | 15,819 | -69.6% | 0.00% | -66.7% |
Q2 2019 | $314,000 | -44.1% | 52,002 | -13.8% | 0.00% | -25.0% |
Q4 2018 | $562,000 | +129.4% | 60,340 | +242.3% | 0.00% | +300.0% |
Q3 2018 | $245,000 | -48.4% | 17,627 | -41.2% | 0.00% | -50.0% |
Q2 2018 | $475,000 | +44.8% | 30,002 | +57.3% | 0.00% | 0.0% |
Q1 2018 | $328,000 | -25.6% | 19,076 | +56.4% | 0.00% | -33.3% |
Q1 2017 | $441,000 | +6200.0% | 12,200 | +3966.7% | 0.00% | – |
Q2 2015 | $7,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |